![Charles A. Nicolette](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles A. Nicolette
Vorstandsvorsitzender bei CoImmune, Inc.
Aktive Positionen von Charles A. Nicolette
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CoImmune, Inc.
![]() CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Charles A. Nicolette
Ehemalige bekannte Positionen von Charles A. Nicolette
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARGOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2003 | 30.11.2018 |
Genzyme Molecular Oncology
![]() Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis. | Corporate Officer/Principal | 01.01.1997 | 01.01.2003 |
Antigen Discovery | Direktor/Vorstandsmitglied | 01.01.1997 | 01.01.2003 |
Ausbildung von Charles A. Nicolette
The State University of New York | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Argos Therapeutics, Inc.
![]() Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Genzyme Molecular Oncology
![]() Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis. | Health Technology |
Antigen Discovery | |
CoImmune, Inc.
![]() CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Charles A. Nicolette
- Erfahrung